Abstract. Keloid is a type of pathological skin scar. Pathogenesis of keloid is complex and is not fully understood. LncRNA can regulate gene expression on different levels. It also participates in cell cycle regulation and cell proliferation. The present study investigated the potential biological function of lncRNA in keloid. We identified differential expression of lncRNAs and mRNAs between 3 pairs of keloid and normal skin tissue by microarray. Differentially expressed lncRNAs were validated by quantitative reverse transcriptase-PCR (qRT-PCR). Gene Ontology (GO) and pathway analysis presented the characteristics of associated protein-coding genes. Additionally, a co-expression network of lncRNA and mRNA was constructed to find potential underlying regulation targets. There were 1,731 lncRNAs constantly upregulated and 782 downregulated, 1,079 mRNAs upregulated and 3,282 downregulated in keloid respectively (fold change ≥2.0, P<0.05). We chose, respectively, 3 upregulated and 1 downregulated lncRNA for qRT-PCR and results were consistent with microarray. Moreover, 11 pathways were related with upregulated transcripts and 44 with downregulated in keloid. The co-expression network revealed that one lncRNA was connected with numerous mRNAs, and vice versa. Furthermore, bioinformation analysis suggested that lncRNA CACNA1G-AS1 may be crucial to keloid formation. In conclusion, groups of lncRNAs were aberrantly expressed in keloid compared with normal skin tissue, which indicated that differentially expressed lncRNAs may play a key role in keloid formation. The present study provides new insights into keloid pathology and potential targets for treatment of keloid.
Introduction
Keloid is a benign tumor with characteristics of hyperproliferation of fibroblasts and excessive accumulation of extracellular matrix. This pathological process is often triggered by a skin injury. The lesion invades into the normal skin , and forms a solid nodule which is unable to regress spontaneously (1) . Multiple therapeutic methods have been reported, such as surgery, radiotherapy, hormone injection, intense pulsed light (IPL) and intralesional cryotherapy (2, 3) . However, long-term follow-up has shown a relative high rate of recurrence (4) . New therapies have also been applied recently, while safety and compared effect need to be further examined (5, 6) . To better understand the disease, multiple studies have been conducted to explore the complex pathological mechanism. Nakashima et al (7) identified 4 single nucleotide polymorphism (SNP) loci related to keloid by a multistage genome-wide association study in the Japanese population. Chen et al (8) found 250 upregulated and 152 downregulated genes in keloid compared with normal skin. Moreover, several signaling pathways and transcriptional factors are found associated (9, 10) . However, the precise linkage gene and pathological process are still controversial.
Long non-coding RNA (lncRNA) refers to a class of noncoding RNA, with length more than 200 nt. LncRNA has been confirmed vital to genomic imprinting, dosage compensation, pluripotency-regulation and organism development (11, 12) . Although there are no reports on lncRNA in keloid, it does play an important role in skin homeostasis and diseases (13, 14) . For example, lncRNA such as anti-differentiation non-coding RNA (ANCR) and terminal differentiation-induced non-coding RNA (TINCR) are essential for epidermal stability (15) . A deletion of ANCR induces epidermal differentiation spontaneously (16) .
Considering that lncRNA has a major role in both normal biological growth and pathological development of diseases, we hypothesize it may also participate in keloid formation. In the present study, we adopted high-throughput microarray screening to compare the differences of lncRNA and mRNA expression profiles between keloid and normal skin tissues. Quantitative RT-PCR followed to confirm the results from microarray. By bioinformation analysis, we used the candidate lncRNAs and their potential related protein-coding genes to construct a coding-non-coding gene co-expression diagram. RNA labeling and array hybridization. Sample labeling and array hybridization were performed according to the Agilent One-Color Microarray-Based Gene Expression Analysis protocol (Agilent Technologies) with minor modifications. First, mRNA was purified from total RNA after removal of rRNA (mRNA-ONLY™ Eukaryotic mRNA isolation kit; Epicentre, Madison, WI, USA). Then, each sample was amplified and transcribed into fluorescent cRNA along the entire length of the transcripts without 3' bias utilizing a random priming method (Quick Amp Labeling kit, One-Color; Agilent p/n 5190-0442). The labeled cRNAs were purified by RNeasy Mini kit (Qiagen p/n 74104). The concentration and specific activity of the labeled cRNAs (pmol Cy3/µg cRNA) were measured by NanoDrop ND-1000. Hybridization adopted Agilent Gene Expression Hybridization kit (Agilent p/n 5188-5242). A total of 1 µg of each labeled cRNA was fragmented by adding 5 µl 10X blocking agent (Agilent p/n 5188-5242) and 1 µl of 25X fragmentation buffer (Agilent p/n 5188-5242), then the mixture was heated at 60˚C for 30 min, finally 25 µl 2X GE hybridization buffer (Agilent p/n 5188-5242) was added to dilute the labeled cRNA. A total of 50 µl of hybridization solution was dispensed into the gasket slide and assembled to the lncRNA expression microarray slide. The slides were incubated for 17 h at 65˚C in an Agilent hybridization oven (Agilent p/n G2545A). The hybridized arrays were washed, fixed and scanned using the Agilent DNA G2505C microarray.
Data analysis. Agilent Feature Extraction software (version 11.0.1.1) was used to examine acquired array images. Quantile normalization and subsequent data processing were executed using the GeneSpring GX v11. indicates the significance of the pathway correlated to the conditions. The lower the P-value, the more significant is the pathway. The analysis was performed by Kangcheng Biology Engineering.
The coding-non-coding gene co-expression network. We chose 4 lncRNAs (uc002lfu.1, ENST00000522743, NR_038439 and ENST00000521141) to explore the connection between these lncRNAs and corresponding coding genes. First, the median value of all the transcripts expressed from the same coding gene was selected, while there was no special treatment with the expression value of lncRNA. Secondly, differentially expressed lncRNAs and mRNAs data were screened and taken away from dataset. Thirdly, Pearson correlation coefficient (PCC) between coding gene and lncRNA was calculated using R-value. Fourthly, PCC ≥0.999 was chosen as meaningful related pair. Finally, the network was drawn through Cytoscape (v2.8.1). In the network, we used blue nodes representing coding genes, and red/pink nodes representing lncRNAs. A solid line indicates a positive correlation, and a dashed line a negative correlation.
Quantitative real-time PCR and statistical methods. We used quantitative real-time PCR (qRT-PCR) to confirm the expression levels. Total RNA was extracted from frozen tissue using a TRIzol reagent (Invitrogen Life Technologies) and reversetranscribed using RT reagent kit (Thermo Fisher Scientific) according to the manufacturer's instructions. Real-time PCR was performed using the SYBR-Green method with ViiA 7 real-time PCR system (Applied Biosystems) following the manufacturer's protocols. Three significantly upregulated lncRNAs (uc002lfu.1, ENST00000522743 and NR_038439) and one downregulated lncRNAs (ENST00000521141) were chosen to test the reproducibility of the data. After further research, NR_038439 drew our attention and was tested in 13 other pairs of tissues. Glyceraldehyde three-phosphate dehydrogenase (GAPDH) acted as endogenous control. Primer sequences were as follows: GAPDH: forward, 5'-GGGAAA CTGTGGCGTGAT-3' and reverse, 5'-GAGTGGGTGTCG CTGTTGA-3'; uc002lfu.1: forward, 5'-TGCTTGATCCAAA TAATGCC-3' and reverse, 5'-TTCAGTCCAGAGATGTG CC-3'; ENST00000522743: forward, 5'-AGACCCAAAGCT GACACCA-3' and reverse, 5'-ATCTCCCCTCATCCAAA CC-3'; NR_038439: forward, 5'-CTGGCAAGGTTGAGTA GGCT-3' and reverse, 5'-TGCTCCCTTCACACGGTCA-3'; ENST00000521141: forward, 5'-AAGGATGTGGGAGTTT GAGAC-3' and reverse, 5'-CAGAGGGGAGAGCGTGTTC-3'. The PCR conditions were as follows: PCR reaction under 95˚C for 10 min, then 40 cycles of 95˚C for 10 sec and 60˚C for 60 sec. After setting the concentration of PCR product as 1, all the PCR products were diluted as follows: 1x10
, 1x10 -4 , 1x10 -5 , 1x10 -6 , 1x10 -7 , 1x10 -8 and 1x10 -9 . As the target genes and housekeeping gene went through PCR separately, the standard curves were drawn based on the dilution. The relative expression (RQ) was obtained through dividing the concentration of target gene by the one of housekeeping gene. The lncRNA expression differences between keloid and normal skin were analyzed using Student's t-test with SPSS (version 16.0; SPSS, Inc., Chicago, IL, USA). A value of P<0.05 was considered significant.
Results
Differentially expressed lncRNAs between keloid and normal skin tissues. The microarray we used in the present study can detect 30,586 lncRNAs and 2,6108 annotated mRNAs from authoritative data sources including 'RefSeq', 'UCSC knowngene' and 'Genecode'. We found a total of 16,710 lncRNAs expressed in keloid from lncRNA expression profiling data using microarray analysis (Fig. 1A) . Through these data, we compared lncRNA expression levels among 3 pairs of human keloid and their adjacent normal skin tissue (Fig. 1C ). There were an average of 2,988 upregulated lncRNAs (range from 2,885 to 3,071) and 1,152 downregulated lncRNAs (range from 1,036 to 1,316), which were significantly differentially expressed (≥2.0-fold) ( Fig. 2A) . To make the results more precise and reduce the possibility of false positive, we set the screen standard of lncRNA as follows: The abnormal lncRNA should exist in all 3 pairs of tissues. After screening, there were 1,731 constantly upregulated lncRNAs and 782 downregulated lncRNAs in keloid compared with normal skin. Top 25 differentially expressed lncRNAs are listed in Table I . In the upregulated lncRNAs, the maximum fold change was 24.68, which belonged to uc002lfu.1. Moreover, among the downregulated lncRNAs, ENST00000449151 possessed the maximum fold change, which was 84.18. The dendrogram from hierarchical clustering analysis exhibits relationships among lncRNA expression patterns (Fig. 2C) .
Differentially expressed mRNAs between keloid and normal skin tissues. The mRNA expression profiling data showed a total of 18,788 mRNAs in keloid using microarray analysis (Fig. 1B) . After comparing the three keloids with their paired adjacent normal skin tissue (Fig. 1D) , we found an average of 1,799 upregulated mRNAs (range from 1,643 to 1,975) and 3,784 downregulated mRNAs (range 3,516 from 4,035) which were significantly differentially expressed (fold change ≥2.0) (Fig. 2B) . In the three paired samples, 1,079 mRNAs were consistently upregulated and 3,282 were consistently downregulated. Top 25 differentially expressed mRNAs are listed in Table II . In the upregulated mRNAs, NM_003014 possessed the maximum fold change, which was 18.22. In the downregulated mRNAs, NM_053283 had the maximum fold change, which was 6366.20. The clustering analysis showed relationships among the mRNA expression patterns, which were present in the samples (Fig. 2D) .
GO analysis and pathway analysis. GO analysis was used to
analyze the main function of the closest coding genes according to the GO database. We found that in upregulated transcripts from keloid, the highest enriched GOs were biological regulation (biological process) (Fig. 3A) , membrane (cellular component) (Fig. 3B) , and receptor activity (molecular function) (Fig. 3C) . Also, in the downregulated transcripts, the highest enriched GOs were cellular process (biological process) (Fig. 3D) , cell part/cell (cellular component) (Fig. 3E) , and binding (molecular function) (Fig. 3F) . In pathway analysis, there were a total of 11 pathways related with upregulated transcripts in keloid (Fig. 4A) . The most enriched network was Neuroactive ligand-receptor interaction, Homo sapiens (human). Also, 44 pathways were found related with downregulated transcripts in keloid (Fig. 4B) . Among them, the most enriched network was valine, leucine and isoleucine degradation, Homo sapiens (human). It is interesting that calcium pathway signaling was one of the items above. Considering calcium played a vital role in wound healing, a common process in keloid formation and calcium ion influx inhibitor was used for keloid treatment (17), calcium pathway signaling was important in pathological behavior.
Construction of the co-expression network.
We built a co-expression network using correlation analysis between differentially expressed lncRNAs (uc002lfu.1, ENST00000522743, NR_038439, ENST00000521141) and mRNAs (Fig. 5) . LncRNAs and mRNAs with Pearson correlation coefficients not less than 0.999 were chosen to draw the network by Cytoscape (v2.8.1). There were 4 lncRNAs and 298 mRNAs in this network, 302 nodes possessed 304 pairs of connections between lncRNAs and mRNAs. The network was complex and indicated that one lncRNA was associated with multiple mRNAs, and vice versa.
Validation of the microarray finding by qRT-PCR.
In order to validate the results from microarray, we selected 3 upregulated (uc002lfu.1, ENST00000522743 and NR_038439) and 1 downregulated lncRNA (ENST00000521141) from the differentially expressed lncRNA profile, then performed quantitative RT-PCR in original tissues. All of the chosen lncRNAs exhibited abundant expression and had significant changes between the two groups in microarray. The results of qRT-PCR were consistent with microarray data (Fig. 6A) . Because calcium signaling pathway may be related with keloid, we chose NR_038439 (lncRNA CACNA1G-AS1), an antisense RNA to CACNA1G which encodes a subtype of T-type Ca 2+ channels, and performed qRT-PCR in another 13 pairs of examples. The result was consistent (P<0.05) (Fig. 6B) . Table I . Top 25 differentially expressed lncRNAs with >2-fold change in 3 paired keloid (K) compared with normal skin tissue (N). 
Upregulated lncRNAs Downregulated lncRNAs ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Discussion
In the present study, we have identified a group of lncRNAs and mRNAs, which had abnormal expression in keloid. To the best of our knowledge, this is the first large-scale lncRNA screening, and study of its role in keloid. Non-coding RNA has been investigated in keloid, and there are many exciting reports (18) . Liu et al (19) used miRNA microarray in 13 couples of keloid and normal skin, and a total of 32 miRNAs were found with abnormal expression in keloid. They also found that miR-21 could affect apoptosis of keloid fibroblast by negatively regulating the expression of PTEN (20) . Compared with microRNA, lncRNA is larger, and has more complex structure. Deregulated expression of lncRNA will disrupt cellular physiology, and then lead to pathologies (21) . Thus, we presumed that it could be vital to the formation of keloid.
LncRNAs are important in both skin homeostasis and diseases. When TINCR is deficient, epidermis is found with abnormal morphological characteristics by absence of keratohyalin granules and lamellar bodies, which are essential for protecting skin from environmental damage (22) . On the other hand, lncRNAs are also crucial in cutaneous malignancies. Vitamin D and its receptor (VDR) are indispensable for preventing epidermal tumor (23), partially due to VDR keeping a balance between oncogenic lncRNAs and tumor suppressors (24) . After comparing lncRNAs in melanoma cell lines, melanocytes and keratinocytes, SPRY4-IT1 was found upregulated in melanoma cells (25) . Following knockdown, the invasion and proliferation of melanoma ceased, and the apoptosis of the cells increase. Mazar and his colleagues found that Lipin 2 was a binding protein to SPRY4-IT1 (26) . They proposed that an abnormal expression of SPRY4-IT1 led to an increased level of Lipin 2, which may cause the disease. The mechanism of how lncRNAs function has not been fully studied, yet several models have been proposed. LncRNAs can perform as molecular signals, decoys, guiding certain protein to specific location and scaffolds (27) . Therefore, further research on lncRNA characterization will help us understand the mechanism of keloid formation, and enable development of personalized therapeutic strategies. By performing microarray profiling, we found 16,710 lncRNAs and 18,788 mRNAs in keloid. Among them, 1,731 lncRNAs were constantly upregulated and 782 were downregulated, whereas, 1,079 mRNAs were consistently upregulated and 3,282 were downregulated. GO analysis showed that upregulated lncRNAs were enriched in biological regulation, while downregulated ones were enriched in cellular process and metabolic process. These also had a tight connection with keloid formation. Using KEGG pathway analysis, we found an obvious change in ECM-receptor interaction, calcium signaling pathway, focal adhesion and mRNA surveillance pathway.
Upregulated lncRNAs Downregulated lncRNAs
After validation by qRT-PCR, lncRNA CACNA1G-AS1 was proven to have high expression in a total of 16 keloid tissues. CACNA1G-AS1 is an antisense RNA to CACNA1G. CACNA1G encodes Cav3.1, which is a subtype of T-type Ca 2+ channels (28) . Cav3.1 was found to be a tumor suppressor (29, 30) . As far as we know, there are no reports on the function of CACNA1G-AS1. On the one hand, we have started to build models to explore its potential function. On the other hand, we are trying to find out how other antisense lncRNAs interact with their target genes, which may give us an inspiration on the current dilemma.
Antisense RNAs are defined as RNAs transcribed either from opposite strand of a protein coding gene or a sense strand-derived RNA (31) . They can either positively or negatively modulate protein-coding genes (32). Xue et al (33) found that in bladder cancer cells, lncRNA MDC1-AS can inhibit malignant cell performance by upregulating the expression of MDC1, a cancer suppressing gene, in both mRNA and protein levels. Our mRNA microarray result showed that CACNA1G also exhibited higher expression level in keloid. Thus, we presumed that CACNA1G-AS1 might regulate the pathological process in keloid through interacting with CACNA1G. More experiments are needed to explore the hypothesis. The L-type calcium channel blocker verapamil, has already been used in clinical treatment for keloid and proven effective (34) . An 18-month follow-up of clinical study showed that in a group of patients who received intralesional verapamil hydrochloride injections after surgery, keloid was cured in 54% of them, compared to 18% in the control group who received the same therapy except verapamil (35) . Some researchers believe that hypertension is one of the reasons that may cause keloid, thus anti-hypertension pharmaceuticals such as verapamil is useful (36) . Verapamil can also decrease the production of cytokines such as IL-6 and VEGF in central keloid fibroblasts, which are responsible for irregular proliferation of keloid fibroblasts (37) . Based on these theories, we propose that Cav3.1 blocker may also be valid in treating keloid in a similar way.
Besides the CACNA1G, we found 26 other genes related to CACNA1G-AS1 in the co-expression network. They were RABGAP1, TTC18, PDPN, TUBB6, WDR3, ACP1, WFDC12, DPT, SIGMAR1, LGALSL, IBSP, ODF3, ZNF429, CHMP5, RNF6, ALOX15B, TF, SLC35F5, FGFBP1, NPL, VIMP, TRC, CCT7, SFRP4, CATSPER2 and CKAP5. Many of them are involved in cell proliferation and preventing cell apoptosis, which are commonly seen in keloid. Dermatopontin (DPT) participates in wound healing by activating fibronectin and improving cell adhesion (38) . CHMP5, a multivesicular body, can inhibit cell apoptosis. When expression of CHMP5 is inhibited in leukemic cells, caspase-3 is activated, and apoptosis is stimulated (39) . FGFBP1, known as FGFBP, is upregulated in several types of tumors and critical for tumor angiogenesis (40) . More research should be done to establish related regulation mechanisms between these coding and noncoding genes.
In conclusion, we profiled differentially expressed lncRNAs and mRNAs in keloid and normal skin tissue. Further information on the candidate lncRNAs and their associated protein-coding genes were also studied. CACNA1G-AS1 was upregulated in keloid, and it may be important in keloid formation. However, further studies of the possible mechanism are required. Our findings indicate that lncRNAs are involved in the pathological process of keloid, which may help to explain the mechanism of keloid formation. 
